Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

lipid nanoparticle encapsulating glutathione S-transferase P siRNA NBF-006

A biodegradable, lyophilized lipid nanoparticle (LNP) encapsulating small interfering ribonucleic acid (siRNA) directed against glutathione S-transferase P (GSTP), with potential antineoplastic activity. Upon administration of LNP encapsulating GSTP siRNA NBF-006, the LNP formulation delivers the siRNA particles to the tumor cells where the GSTP siRNA targets and binds to GSTP mRNA. This results in the inhibition of the translation and expression of GSTP and may inhibit proliferation of KRAS-overexpressing tumor cells. GSTP, an enzyme overexpressed in many tumor cell types, is involved in modulating MAP kinase-related cell-signaling pathways.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:lipid nanoparticle encapsulating GSTP siRNA NBF-006
siRNA-based lipid nanoparticle NBF-006
siRNA-based LNP NBF-006
Code name:NBF 006
NBF-006
NBF006
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search